This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brouqui, P. Articles by Raoult, D. Search for Related Content PubMed PubMed Citation Articles by Brouqui, P. Articles by Raoult, D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 11 1995, 2423-2425, Vol 39, No. 11
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination

P Brouqui, MC Rousseau, A Stein, M Drancourt and D Raoult
Microbiologie Clinique, Centre Hospitalier Universitaire, Marseille, France.

Indwelling device infections are associated with considerable morbidity and extremely high cost. Pseudomonas aeruginosa is the most frequent gram-negative etiologic agent associated with infections of indwelling catheters and foreign body implants. It is generally agreed that eradication of infection in the presence of a foreign body requires removal of the foreign body. Using a combination of ceftazidime and ciprofloxacin, we cured nine of nine patients with P. aeruginosa- infected osteosynthetic material and four of five patients with hip and knee prostheses without removing the foreign material. Follow-up was for a mean of 21 months (range, 6 to 60 months). Some patients experienced minor side effects (arthralgia in one patient and rash in another patient). We conclude that this combination is effective and safe and should be useful in the treatment of P. aeruginosa-infected orthopedic implants.

This article has been cited by other articles:

• Samuel, J. R., Gould, F. K. (2009). Prosthetic joint infections: single versus combination therapy. J Antimicrob Chemother 0: dkp398v1-dkp398 [Abstract] [Full Text]  
• Martinez-Pastor, J. C., Munoz-Mahamud, E., Vilchez, F., Garcia-Ramiro, S., Bori, G., Sierra, J., Martinez, J. A., Font, L., Mensa, J., Soriano, A. (2009). Outcome of Acute Prosthetic Joint Infections Due to Gram-Negative Bacilli Treated with Open Debridement and Retention of the Prosthesis. Antimicrob. Agents Chemother. 53: 4772-4777 [Abstract] [Full Text]  
• Botelho-Nevers, E., Gouriet, F., Rovery, C., Paris, P., Roux, V., Raoult, D., Brouqui, P. (2005). First Case of Osteomyelitis Due to Shewanella algae. J. Clin. Microbiol. 43: 5388-5390 [Abstract] [Full Text]  
• Roux, V., Drancourt, M., Stein, A., Riegel, P., Raoult, D., La Scola, B. (2004). Corynebacterium Species Isolated from Bone and Joint Infections Identified by 16S rRNA Gene Sequence Analysis. J. Clin. Microbiol. 42: 2231-2233 [Abstract] [Full Text]  
• Bernard, L., Hoffmeyer, P., Assal, M., Vaudaux, P., Schrenzel, J., Lew, D. (2004). Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother 53: 127-129 [Abstract] [Full Text]  
• Stein, A., Bataille, J. F., Drancourt, M., Curvale, G., Argenson, J. N., Groulier, P., Raoult, D. (1998). Ambulatory Treatment of Multidrug-Resistant Staphylococcus-Infected Orthopedic Implants with High-Dose Oral Co-trimoxazole (Trimethoprim-Sulfamethoxazole). Antimicrob. Agents Chemother. 42: 3086-3091 [Abstract] [Full Text]